Apogee Therapeutics (APGE) Assets Average (2023 - 2026)

Apogee Therapeutics (APGE) has 4 years of Assets Average data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Assets Average rose 51.95% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 51.95% YoY) and the FY2025 annual result came in at $845.5 million, up 46.37% from the prior year.
• Assets Average rose to $1.1 billion in Q1 2026 per APGE's latest filing, from $781.6 million in the prior quarter.
• Across five years, Assets Average topped out at $1.1 billion in Q1 2026 and bottomed at $278.5 million in Q3 2023.
• The 4-year median for Assets Average is $734.1 million (2025), against an average of $693.6 million.
• The widest annual swing landed in 2024, when Assets Average soared 183.07%; it then fell 18.58% in 2025.
• Tracing APGE's Assets Average over 4 years: stood at $413.9 million in 2023, then jumped by 84.85% to $765.1 million in 2024, then climbed by 2.16% to $781.6 million in 2025, then surged by 42.7% to $1.1 billion in 2026.
• Per Business Quant, the three latest APGE Assets Average figures stand at $1.1 billion (Q1 2026), $781.6 million (Q4 2025), and $642.0 million (Q3 2025).

Peer Comparison